These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
559 related items for PubMed ID: 24585268
21. Effect of a splice site mutation in LDLR gene and two variations in PCSK9 gene in Tunisian families with familial hypercholesterolaemia. Jelassi A, Slimani A, Jguirim I, Najah M, Maatouk F, Varret M, Slimane MN. Ann Clin Biochem; 2011 Jan; 48(Pt 1):83-6. PubMed ID: 21115573 [Abstract] [Full Text] [Related]
29. Moderate phenotypic expression of familial hypercholesterolemia in Tunisia. Jelassi A, Slimani A, Jguirim I, Najah M, Abid A, Boughamoura L, Mzid J, Fkih M, Maatouk F, Rouis M, Varret M, Slimane MN. Clin Chim Acta; 2010 May 02; 411(9-10):735-8. PubMed ID: 20144596 [Abstract] [Full Text] [Related]
32. Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia. Abifadel M, Guerin M, Benjannet S, Rabès JP, Le Goff W, Julia Z, Hamelin J, Carreau V, Varret M, Bruckert E, Tosolini L, Meilhac O, Couvert P, Bonnefont-Rousselot D, Chapman J, Carrié A, Michel JB, Prat A, Seidah NG, Boileau C. Atherosclerosis; 2012 Aug 02; 223(2):394-400. PubMed ID: 22683120 [Abstract] [Full Text] [Related]
35. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study. Pek SLT, Dissanayake S, Fong JCW, Lin MX, Chan EZL, Tang JI, Lee CW, Ong HY, Sum CF, Lim SC, Tavintharan S. Atherosclerosis; 2018 Feb 02; 269():106-116. PubMed ID: 29353225 [Abstract] [Full Text] [Related]
36. Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial. Raal FJ, Honarpour N, Blom DJ, Hovingh GK, Xu F, Scott R, Wasserman SM, Stein EA, TESLA Investigators. Lancet; 2015 Jan 24; 385(9965):341-50. PubMed ID: 25282520 [Abstract] [Full Text] [Related]